Maryland State Retirement & Pension System’s Meridian Bioscience Inc VIVO Stock Holding History

Maryland State Retirement & Pension System’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-18,087	Closed	-$601K	–	1562
2022 Q4	$601K	Buy	+18,087	New	+$583K	0.02%	859
2022 Q3	–	Sell	-17,660	Closed	-$537K	–	1473
2022 Q2	$537K	Buy	17,660 +274	+2%	+$7.41K	0.02%	896
2022 Q1	$451K	Buy	17,386 +159	+0.9%	+$3.78K	0.01%	1132
2021 Q4	$351K	Hold	17,227	–	–	0.01%	1295
2021 Q3	$343K	Buy	+17,227	New	+$343K	0.01%	1311

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Maryland State Retirement & Pension System's VIVO Position: Q1 2023 in Review

Maryland State Retirement & Pension System sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 18,087 shares — an estimated $601K sold.

Maryland State Retirement & Pension System first reported a position in VIVO in Q3 2021 and held it in 5 quarters. The position peaked at $601K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Maryland State Retirement & Pension System reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Maryland State Retirement & Pension System sold 18,087 Meridian Bioscience Inc shares in Q1 2023, an estimated $601K.
Maryland State Retirement & Pension System first reported a position in Meridian Bioscience Inc in Q3 2021 and held it in 5 quarters.
Maryland State Retirement & Pension System's Meridian Bioscience Inc position peaked at $601K in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Maryland State Retirement & Pension System's 13F filing for Q1 2023, filed 20 Apr 2023.